The optional approach of oncogene-addicted non-small cell lung cancer with brain metastases in the new generation targeted therapies era

von Spagnuolo, Alessia, Muto, Matteo, Monaco, Fabio, Colantuoni, Giuseppe, Gridelli, Cesare
Veröffentlicht in Transl Lung Cancer Res (2019)

Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Regi...

von Riccardi, Ferdinando, Colantuoni, Giuseppe, Diana, Anna, Mocerino, Carmela, Cartenì, Giacomo, Lauria, Rossella, Febbraro, Antonio, Nuzzo, Francesco, Addeo, Raffaele, Marano, Ombretta, Incoronato, Pasquale, De Placido, Sabino, Ciardiello, Fortunato, Orditura, Michele
Veröffentlicht in Mol Clin Oncol (2018)

Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting

von Prete, Salvatore Del, Montella, Liliana, Arpino, Grazia, Buono, Giuseppe, Buonerba, Carlo, Dolce, Pasquale, Fiorentino, Olga, Aliberti, Maria, Febbraro, Antonio, Savastano, Clementina, Colantuoni, Giuseppe, Riccardi, Ferdinando, Ruggiero, Angela, Placido, Sabino De, Orditura, Michele
Veröffentlicht in Oncotarget (2020)

Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer

von Puglisi, Fabio, Gerratana, Lorenzo, Lambertini, Matteo, Ceppi, Marcello, Boni, Luca, Montemurro, Filippo, Russo, Stefania, Bighin, Claudia, De Laurentiis, Michelino, Giuliano, Mario, Bisagni, Giancarlo, Durando, Antonio, Turletti, Anna, Garrone, Ornella, Ardizzoni, Andrea, Gamucci, Teresa, Colantuoni, Giuseppe, Gravina, Adriano, De Placido, Sabino, Cognetti, Francesco, Del Mastro, Lucia
Veröffentlicht in NPJ Breast Cancer (2021)